All news & updates
BillingOntario

Executive Officer Notice: Funding of omalizumab under the Ontario Drug Benefit Program

Ontario Public Drug Programs notice (PDF). Effective date: August 29, 2025.

Read the source: Executive Officer (EO) Communications

ScopeUp collects Ontario and national pharmacy practice updates and links every item to its source. Verify details against the source document before changing workflows.